| Diseases | Fatty liver | News
Fatty liver disease and alcohol tolerance

A large study shows that daily alcohol consumption, even in small amounts, worsens liver fibrosis in patients with metabolic liver disease.

| Fatty liver | News | Treatments
Vitamin E for fatty liver disease

A large study reveals that vitamin E can reduce liver fibrosis and improve liver health in patients, reinforcing its therapeutic value alongside diet and exercise.

| Autoinmune hepatitis | News | Treatments
Infliximab treatment for autoimmune hepatitis

Infliximab shows positive results in autoimmune hepatitis resistant to conventional therapies, improving liver function in most patients and representing a potential future treatment option.

| Fatty liver | Health | News
Menarche and fatty liver

Women with early menarche show a higher risk of fatty liver disease. Later onset lowers this risk, highlighting the importance of monitoring weight and liver health.

| Health | Healthy nutrition | News
New drug for the treatment of obesity

MariTide, a new drug for obesity, delivers significant weight loss with a single monthly injection, while also reducing blood pressure and glucose levels in patients.

| Fatty liver | Healthy nutrition | News
Manganese and fatty liver

A study links elevated blood manganese levels with a higher risk of liver disease. Controlling dietary intake and workplace exposure is crucial to reduce this risk and protect health.

| Health | News
Weight loss drugs: Semaglutide vs Tirzepatide

A comparative study found that tirzepatide outperforms semaglutide for weight loss, achieving greater reductions in body weight, waist circumference, and blood pressure, with similar side effects in both treatments.

| News | Treatments
Treatment of pruritus in primary biliary cholangitis

Linerixibat, a bile acid transport inhibitor, has shown significant benefits in the treatment of pruritus in primary biliary cholangitis, reducing itching and improving sleep with minimal side effects.

| Fatty liver | News | Treatments
Research of a new drug for fatty liver

A promising new treatment for fatty liver disease has outperformed existing medications like Ozempic and Mounjaro in reducing liver fat, according to a recent study presented at a major liver disease conference.

| Hepatitis B | News | Treatments
Development of a new drug for the treatment of Hepatitis B virus

Hepalatide, used with pegylated interferon-alpha, shows promise for curing chronic hepatitis B by eliminating cccDNA from liver cells, according to early study results presented in a European liver congress.

About Us

The Foundation for the Study of Viral Hepatitis is a benchmark in the field of hepatology worldwide, with the best specialists in liver diseases and molecular biology. A clinic specialized in internal medicine, liver and digestive system in Madrid

© 2018 - 2026 FEHV Clinic. All rights reserved.  Privacy Policy.  Cookies Policy.  Legal Notice.